Results 251 to 260 of about 69,470 (266)

Trends in antifungal susceptibility testing using CLSI reference and commercial methods

Expert Review of Anti-Infective Therapy, 2009
Emilia Canton, Javier Peman, Ana Espinel-Ingroff   +2 more
exaly  

Assessment of the antifungal susceptibility of in various media using a CLSI protocol

Veterinary Microbiology, 2012
Maria Teresa Montagna, Claudia Cafarchia, Domenico Otranto   +2 more
exaly  

Update on antifungal susceptibility: CLSI focus

Pathology, 2017
openaire   +1 more source

Toward Harmonization of Voriconazole CLSI and EUCAST Breakpoints for Candida albicans Using a Validated In Vitro Pharmacokinetic/Pharmacodynamic Model.

Antimicrobial Agents and Chemotherapy, 2020
Maiken C Arendrup, Maria Siopi
exaly  

Comparison of E-Test, disk diffusion and a modified CLSI broth microdilution (M 38-A) method for in vitro testing of itraconazole, fluconazole and voriconazole against dermatophytes.

Medical Mycology, 2008
Javier Peman, Estrella Martín-Mazuelos
exaly  

193 ClSi+ X 1Σ+ Chlorosilyliumylidene

2012
openaire   +1 more source

Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 Systemically active antifungal agents when tested against spp.

Diagnostic Microbiology and Infectious Disease, 2014
Paul Rhomberg, Mariana Castanheira, Michael A. Pfaller   +2 more
exaly  

The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agents in vitro

Expert Review of Anti-Infective Therapy, 2010
Manuel Cuenca-Estrella, Juan Luis Rodriguez-Tudela   +1 more
exaly  

CLSI activity in clinical laboratory medicine

臨床検査, 2012
openaire   +1 more source

Assessment of the comparability of CLSI, EUCAST and Stokes antimicrobial susceptibility profiles for Escherichia coli uropathogenic isolates

British Journal of Biomedical Science, 2018
Brigid Lucey, Ciaran J O'Halloran
exaly